Cases & Deals

Canaccord Genuity underwrites follow-on public offering of Common Stock by GenMark Diagnostics

Clients Canaccord Genuity Inc.

Jones Day advised Canaccord Genuity Inc., as representative of the underwriters, in connection with the $34.5 million follow-on public offering of Common Stock on the NASDAQ Global Market by GenMark Diagnostics, Inc., a molecular diagnostics company focused on developing and commercializing proprietary eSensor detection technology.

We use cookies to deliver our online services. Details of the cookies and other tracking technologies we use and instructions on how to disable them are set out in our Cookies Policy. By using this website you consent to our use of cookies.